220 Users Online
The gastrointestinal Stromal Tumor market is segmented by the indication that is Stomach, Small Intestine, and by treatments that are Targeted Drug Therapy, Chemotherapy, Radiation Therapy, Surgery.
1. Global Economic Outlook
2. Global Gastrointestinal Stromal Tumor Market - Executive Summary
3. Global Gastrointestinal Stromal Tumor Market Overview
3.1. Introduction
3.1.1. Global Gastrointestinal Stromal Tumor Market Taxonomy
3.1.2. Global Gastrointestinal Stromal Tumor Market Definition
3.2. Global Gastrointestinal Stromal Tumor Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Gastrointestinal Stromal Tumor Market Y-o-Y Growth
3.3. Global Gastrointestinal Stromal Tumor Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Pricing Analysis
3.7. Drug Pipeline Assessment
3.8. PESTL Analysis
3.9. List of Distributors
3.10. Key Participant Market Presence (Intensity) Map
4. Global Gastrointestinal Stromal Tumor Market Analysis and Forecast 2012-2026
4.1. Global Gastrointestinal Stromal Tumor Market Size and Forecast By Indication, 2012-2026
4.1.1. Stomach Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Small Intestine Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Others Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.2. Global Gastrointestinal Stromal Tumor Market Size and Forecast By End User, 2012-2026
4.2.1. Hospitals Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Clinics Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Specialized Cancer Treatment Centers Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.2.4. Other End Users Market Size and Forecast, 2012-2026
4.2.4.1. Revenue (US$ Mn) Comparison, By Region
4.2.4.2. Market Share Comparison, By Region
4.2.4.3. Y-o-Y growth Comparison, By Region
4.3. Global Gastrointestinal Stromal Tumor Market Size and Forecast By Treatment Type, 2012-2026
4.3.1. Targeted Drug Therapy Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Chemotherapy Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.3.3. Radiation Therapy Market Size and Forecast, 2012-2026
4.3.3.1. Revenue (US$ Mn) Comparison, By Region
4.3.3.2. Market Share Comparison, By Region
4.3.3.3. Y-o-Y growth Comparison, By Region
4.3.4. Surgery Market Size and Forecast, 2012-2026
4.3.4.1. Revenue (US$ Mn) Comparison, By Region
4.3.4.2. Market Share Comparison, By Region
4.3.4.3. Y-o-Y growth Comparison, By Region
4.3.5. Other Therapies Market Size and Forecast, 2012-2026
4.3.5.1. Revenue (US$ Mn) Comparison, By Region
4.3.5.2. Market Share Comparison, By Region
4.3.5.3. Y-o-Y growth Comparison, By Region
5. North America Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Indication
5.6. Revenue (US$ Mn) Comparison, By End User
5.7. Revenue (US$ Mn) Comparison, By Treatment Type
6. Latin America Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Indication
6.6. Revenue (US$ Mn) Comparison, By End User
6.7. Revenue (US$ Mn) Comparison, By Treatment Type
7. Europe Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Rest of Europe Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Indication
7.6. Revenue (US$ Mn) Comparison, By End User
7.7. Revenue (US$ Mn) Comparison, By Treatment Type
8. Japan Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Indication
8.6. Revenue (US$ Mn) Comparison, By End User
8.7. Revenue (US$ Mn) Comparison, By Treatment Type
9. APEJ Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
9.1. APEJ Outlook
9.2. APEJ Parent Market Outlook
9.3. APEJ Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. China Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. India Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Thailand Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Singapore Market Size and Forecast (US$ Mn), 2012-2026
9.4.5. Australia Market Size and Forecast (US$ Mn), 2012-2026
9.4.6. Rest of APEJ Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Indication
9.6. Revenue (US$ Mn) Comparison, By End User
9.7. Revenue (US$ Mn) Comparison, By Treatment Type
10. MEA Gastrointestinal Stromal Tumor Market Size and Forecast, 2012-2026
10.1. MEA Outlook
10.2. MEA Parent Market Outlook
10.3. MEA Target Market Outlook
10.4. Revenue (US$ Mn) Comparison, By Country
10.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
10.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
10.4.3. Nigeria Market Size and Forecast (US$ Mn), 2012-2026
10.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
10.5. Revenue (US$ Mn) Comparison, By Indication
10.6. Revenue (US$ Mn) Comparison, By End User
10.7. Revenue (US$ Mn) Comparison, By Treatment Type
11. Global Gastrointestinal Stromal Tumor Market Company Share, Competition Landscape and Company Profiles
11.1. Company Share Analysis
11.2. Competition Landscape
11.3. Company Profiles
11.3.1. Novartis AG
11.3.2. Sun Pharmaceutical Industries Limited
11.3.3. Pfizer Inc.
11.3.4. Bayer Aktiengesellschaft
11.3.5. NATCO Pharma Limited
12. Research Methodology
13. Secondary and Primary Sources
14. Assumptions and Acronyms
15. Disclaimer
FREE Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
TABLE 1: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017
TABLE 2: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2018-2026
TABLE 3: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4: Global Stomach Segment Value (US$ Mn), By Region 2012-2017
TABLE 5: Global Stomach Segment Value (US$ Mn), By Region 2018-2026
TABLE 6: Global Stomach Segment Market Share, By Region 2012-2017
TABLE 7: Global Stomach Segment Market Share, By Region 2018-2026
TABLE 8: Global Stomach Segment Y-o-Y, By Region 2017-2026
TABLE 9: Global Small Intestine Segment Value (US$ Mn), By Region 2012-2017
TABLE 10: Global Small Intestine Segment Value (US$ Mn), By Region 2018-2026
TABLE 11: Global Small Intestine Segment Market Share, By Region 2012-2017
TABLE 12: Global Small Intestine Segment Market Share, By Region 2018-2026
TABLE 13: Global Small Intestine Segment Y-o-Y, By Region 2017-2026
TABLE 14: Global Others Segment Value (US$ Mn), By Region 2012-2017
TABLE 15: Global Others Segment Value (US$ Mn), By Region 2018-2026
TABLE 16: Global Others Segment Market Share, By Region 2012-2017
TABLE 17: Global Others Segment Market Share, By Region 2018-2026
TABLE 18: Global Others Segment Y-o-Y, By Region 2017-2026
TABLE 19: Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
TABLE 20: Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
TABLE 21: Global Hospitals Segment Market Share, By Region 2012-2017
TABLE 22: Global Hospitals Segment Market Share, By Region 2018-2026
TABLE 23: Global Hospitals Segment Y-o-Y, By Region 2017-2026
TABLE 24: Global Clinics Segment Value (US$ Mn), By Region 2012-2017
TABLE 25: Global Clinics Segment Value (US$ Mn), By Region 2018-2026
TABLE 26: Global Clinics Segment Market Share, By Region 2012-2017
TABLE 27: Global Clinics Segment Market Share, By Region 2018-2026
TABLE 28: Global Clinics Segment Y-o-Y, By Region 2017-2026
TABLE 29: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2012-2017
TABLE 30: Global Specialized Cancer Treatment Centers Segment Value (US$ Mn), By Region 2018-2026
TABLE 31: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2012-2017
TABLE 32: Global Specialized Cancer Treatment Centers Segment Market Share, By Region 2018-2026
TABLE 33: Global Specialized Cancer Treatment Centers Segment Y-o-Y, By Region 2017-2026
TABLE 34: Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
TABLE 35: Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
TABLE 36: Global Other End Users Segment Market Share, By Region 2012-2017
TABLE 37: Global Other End Users Segment Market Share, By Region 2018-2026
TABLE 38: Global Other End Users Segment Y-o-Y, By Region 2017-2026
TABLE 39: Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 40: Global Targeted Drug Therapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 41: Global Targeted Drug Therapy Segment Market Share, By Region 2012-2017
TABLE 42: Global Targeted Drug Therapy Segment Market Share, By Region 2018-2026
TABLE 43: Global Targeted Drug Therapy Segment Y-o-Y, By Region 2017-2026
TABLE 44: Global Chemotherapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 45: Global Chemotherapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 46: Global Chemotherapy Segment Market Share, By Region 2012-2017
TABLE 47: Global Chemotherapy Segment Market Share, By Region 2018-2026
TABLE 48: Global Chemotherapy Segment Y-o-Y, By Region 2017-2026
TABLE 49: Global Radiation Therapy Segment Value (US$ Mn), By Region 2012-2017
TABLE 50: Global Radiation Therapy Segment Value (US$ Mn), By Region 2018-2026
TABLE 51: Global Radiation Therapy Segment Market Share, By Region 2012-2017
TABLE 52: Global Radiation Therapy Segment Market Share, By Region 2018-2026
TABLE 53: Global Radiation Therapy Segment Y-o-Y, By Region 2017-2026
TABLE 54: Global Surgery Segment Value (US$ Mn), By Region 2012-2017
TABLE 55: Global Surgery Segment Value (US$ Mn), By Region 2018-2026
TABLE 56: Global Surgery Segment Market Share, By Region 2012-2017
TABLE 57: Global Surgery Segment Market Share, By Region 2018-2026
TABLE 58: Global Surgery Segment Y-o-Y, By Region 2017-2026
TABLE 59: Global Other Therapies Segment Value (US$ Mn), By Region 2012-2017
TABLE 60: Global Other Therapies Segment Value (US$ Mn), By Region 2018-2026
TABLE 61: Global Other Therapies Segment Market Share, By Region 2012-2017
TABLE 62: Global Other Therapies Segment Market Share, By Region 2018-2026
TABLE 63: Global Other Therapies Segment Y-o-Y, By Region 2017-2026
TABLE 64: North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 65: North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 66: North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 67: North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 68: North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 69: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
TABLE 70: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
TABLE 71: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
TABLE 72: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
TABLE 73: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
TABLE 74: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
TABLE 75: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 76: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 77: Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 78: Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 79: Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 80: Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 81: Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 82: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
TABLE 83: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
TABLE 84: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
TABLE 85: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
TABLE 86: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
TABLE 87: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
TABLE 88: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 89: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 90: Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 91: Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 92: Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 93: Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 94: Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 95: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
TABLE 96: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
TABLE 97: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
TABLE 98: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
TABLE 99: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
TABLE 100: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
TABLE 101: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 102: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 103: Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 104: Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 105: Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 106: Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 107: Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 108: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
TABLE 109: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
TABLE 110: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
TABLE 111: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
TABLE 112: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
TABLE 113: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
TABLE 114: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 115: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 116: APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 117: APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 118: APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 119: APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 120: APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 121: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
TABLE 122: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
TABLE 123: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
TABLE 124: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
TABLE 125: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
TABLE 126: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
TABLE 127: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 128: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
TABLE 129: MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
TABLE 130: MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
TABLE 131: MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
TABLE 132: MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
TABLE 133: MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
TABLE 134: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
TABLE 135: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
TABLE 136: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
TABLE 137: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
TABLE 138: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
TABLE 139: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
TABLE 140: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
TABLE 141: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
FIG. 1: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn), 2012-2017
FIG. 2: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3: Global Gastrointestinal Stromal Tumor Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4: Global Stomach Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5: Global Stomach Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6: Global Stomach Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7: Global Small Intestine Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8: Global Small Intestine Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9: Global Small Intestine Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10: Global Others Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11: Global Others Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12: Global Others Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13: Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14: Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15: Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16: Global Clinics Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17: Global Clinics Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18: Global Clinics Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20: Global Specialized Cancer Treatment Centers Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21: Global Specialized Cancer Treatment Centers Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22: Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23: Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24: Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25: Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26: Global Targeted Drug Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27: Global Targeted Drug Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28: Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29: Global Chemotherapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30: Global Chemotherapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31: Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32: Global Radiation Therapy Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33: Global Radiation Therapy Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34: Global Surgery Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 35: Global Surgery Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 36: Global Surgery Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 37: Global Other Therapies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 38: Global Other Therapies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 39: Global Other Therapies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 40: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
FIG. 41: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
FIG. 42: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
FIG. 43: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
FIG. 44: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
FIG. 45: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
FIG. 46: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 47: North America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 48: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
FIG. 49: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
FIG. 50: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
FIG. 51: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
FIG. 52: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
FIG. 53: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
FIG. 54: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 55: Latin America Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 56: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
FIG. 57: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
FIG. 58: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
FIG. 59: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
FIG. 60: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
FIG. 61: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
FIG. 62: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 63: Europe Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 64: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
FIG. 65: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
FIG. 66: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
FIG. 67: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
FIG. 68: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 69: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
FIG. 70: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 71: Japan Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 72: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
FIG. 73: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
FIG. 74: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
FIG. 75: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
FIG. 76: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
FIG. 77: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
FIG. 78: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 79: APEJ Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
FIG. 80: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2012-2017
FIG. 81: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Country 2018-2026
FIG. 82: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2012-2017
FIG. 83: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Indication 2018-2026
FIG. 84: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2012-2017
FIG. 85: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By End User 2018-2026
FIG. 86: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2012-2017
FIG. 87: MEA Gastrointestinal Stromal Tumor Market Value (US$ Mn), By Treatment Type 2018-2026
